Document is current
Any future updates will be listed below
-
Authors
Trudzinski, F. C.
Jörres, R. A.
Alter, P.
Kahnert, K.
Waschki, B.
Herr, C.
Kellerer, C.
Omlor, A.
Vogelmeier, C. F.
Fähndrich, S.
Watz, H.
Welte, T.
Jany, B.
Söhler, S.
Biertz, F.
Herth, F.
Kauczor, H.-U.
Bals, R.
,
Andreas, Stefan
Behr, Jürgen
Bewig, Burkhard
Buhl, Roland
Ewert, Ralf
Stubbe, Beate
Ficker, Joachim H.
Gogol, Manfred
Grohé, Christian
Hauck, Rainer
Held, Matthias
Henke, Markus
Höffken, Gerd
Katus, Hugo A.
Kirsten, Anne-Marie
Koczulla, Rembert
Kenn, Klaus
Kronsbein, Juliane
Kropf-Sanchen,
Lange, Christoph
Zabel, Peter
Pfeifer, Michael
Randerath, Winfried J.
Seeger, Werner
Studnicka, Michael
Taube, Christian
Teschler, Helmut
Timmermann, Hartmut
Virchow, J. Christian
Wagner,
Wirtz, Hubert
- License Information
-
More Information
Article History
Received: 4 February 2020
Accepted: 27 May 2020
First Online: 29 June 2020
Competing interests
: F.C. Trudzinski, R.A. Jörres. Kahnert, C. Herr, C. Kellerer, A. Omlor, S. Fähndrich, H. Watz, B. Waschki, B. Jany, S. Söhler, F. Biertz, and F. Herth have nothing to disclose with regard to this study. R. Bals reports grants and personal fees from AstraZeneca, grants and personal fees from Boehringer Ingelheim, personal fees from GlaxoSmithKline, personal fees from Grifols, grants and personal fees from Novartis, personal fees from CSL Behring, grants from German Federal Ministry of Education and Research (BMBF) Competence Network Asthma and COPD (ASCONET), grants from Sander Stiftung, grants from Schwiete Stiftung, grants from Krebshilfe, grants from Mukoviszidose eV, outside the submitted work. H.-U. Kauczor received research support for imaging investigations in the COSYCONET cohort from Bayer and Siemens; as well as research support outside the scope of this study from Philips and honoraria for speakers bureau activities from Boehringer Ingelheim, MSD and Astra Zeneca. CF Vogelmeier reports grants and personal fees from AstraZeneca, grants and personal fees from Boehringer Ingelheim, grants and personal fees from Chiesi, grants and personal fees from GlaxoSmithKline, grants and personal fees from Grifols, grants and personal fees from Mundipharma, grants and personal fees from Novartis, personal fees from Berlin Chemie/Menarini, personal fees from CSL Behring, personal fees from Teva, grants from German Federal Ministry of Education and Research (BMBF) Competence Network Asthma and COPD (ASCONET), personal fees from Nuvaira, personal fees from MedUpdate, outside the submitted work. P. Alter reports grants from German Federal Ministry of Education and Research (BMBF) Competence Network Asthma and COPD (ASCONET), grants from AstraZeneca GmbH, grants and non-financial support from Bayer Schering Pharma AG, grants, personal fees and non-financial support from Boehringer Ingelheim Pharma GmbH & Co. KG, grants and non-financial support from Chiesi GmbH, grants from GlaxoSmithKline, grants from Grifols Deutschland GmbH, grants from MSD Sharp & Dohme GmbH, grants and personal fees from Mundipharma GmbH, grants, personal fees and non-financial support from Novartis Deutschland GmbH, grants from Pfizer Pharma GmbH, grants from Takeda Pharma Vertrieb GmbH & Co. KG, outside the submitted work.T. Welte reports grants from German Ministry of Research and Education (BMBF), during the conduct of the study.
